MRVI Maravai Lifesciences Holdings PE ratio, current and historical analysis
The current PE ratio of MRVI cannot be calculated, as the latest EPS of -$1.64 is negative. The last PE ratio of Maravai Lifesciences Holdings, recorded in September 2023, was 55.56.
MRVI PE ratio history
The PE ratio of Maravai Lifesciences Holdings has averaged 15.98 over the last five years. Looking back at the last five years, MRVI's PE ratio peaked in the Sep 2023 quarter at 55.56, when the price was $10 and the EPS was $0.18. The lowest point was in the Dec 2020 quarter, when it reached 3.78 with a price of $28.05 and an EPS of $7.43.
Maravai Lifesciences Holdings PE ratio by year
Maximum annual increase: 597.09% in 2021
Maximum annual decrease: -67.48% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | N/A | N/A | $6.55 | -$0.9 |
| 2022 | 8.57 | -67.48% | $14.31 | $1.67 |
| 2021 | 26.35 | 597.09% | $41.9 | $1.59 |
| 2020 | 3.78 | N/A | $28.05 | $7.43 |
| 2019 | N/A | N/A | N/A | -$0.03 |
| 2018 | N/A | N/A | N/A | -$0.07 |
Maravai Lifesciences Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | N/A | N/A | $8.31 | -$1.64 |
| Jun 2024 | N/A | N/A | $7.16 | -$0.99 |
| Mar 2024 | N/A | N/A | $8.67 | -$0.99 |
| Dec 2023 | N/A | N/A | $6.55 | -$0.9 |
| Sep 2023 | 55.56 | 154.75% | $10 | $0.18 |
| Jun 2023 | 21.81 | 80.55% | $12.43 | $0.57 |
| Mar 2023 | 12.08 | 40.96% | $14.01 | $1.16 |
| Dec 2022 | 8.57 | -38.92% | $14.31 | $1.67 |
| Sep 2022 | 14.03 | -4.17% | $25.53 | $1.82 |
| Jun 2022 | 14.64 | -23.63% | $28.41 | $1.94 |
| Mar 2022 | 19.17 | -27.25% | $35.27 | $1.84 |
| Dec 2021 | 26.35 | 348.89% | $41.9 | $1.59 |
| Sep 2021 | 5.87 | 12.88% | $49.08 | $8.36 |
| Jun 2021 | 5.2 | 10.64% | $41.73 | $8.02 |
| Mar 2021 | 4.7 | 24.34% | $35.64 | $7.58 |
MRVI average PE ratio chart
MRVI PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NBIX Neurocrine Biosciences Inc | 39.49 | $15.43B |
| NVAX Novavax Inc | N/A | $1.35B |
| NVCR NovoCure Ltd | N/A | $2.56B |
| MRVI Maravai Lifesciences Holdings Inc | N/A | $1.2B |
Frequently asked questions
What is Maravai Lifesciences Holdings's PE ratio?
The current price to earnings ratio of MRVI cannot be determined, as its EPS of -$1.64 is negative.
What is the 3-year average PE ratio for Maravai Lifesciences Holdings (MRVI)?
The average PE ratio for MRVI stock over the past 3 years is 20.84.
What is the highest PE ratio for MRVI?
Over the last five years, the quarterly PE ratio reached its highest level at 55.56 in the Sep 2023 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.